Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Colorectal Neoplasms 56 Stomach Neoplasms 27 Pancreatic Neoplasms 18 Rectal Neoplasms 16 Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 11 Neoplasm Metastasis 11 Esophageal Squamous Cell Carcinoma 8 Esophageal Neoplasms 8 Colonic Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Hepatocellular 8 Adenocarcinoma 8 Head and Neck Neoplasms 7 Gastrointestinal Neoplasms 7 Biliary Tract Neoplasms 6 Adenocarcinoma Of Esophagus 6 Ovarian Neoplasms 5 Peritoneal Neoplasms 4 Advanced Solid Tumors 4 Urinary Bladder Neoplasms 3 Nasopharyngeal Carcinoma 3 Lung Neoplasms 3 Endometrial Neoplasms 3 Cholangiocarcinoma 3 Carcinoma, Transitional Cell 3 Carcinoma 3 Breast Neoplasms 3 Appendiceal Neoplasms 3 Locally Recurrent Rectal Cancer 2

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ampullary Adenocarcinoma × Fluorouracil × Clear all

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡